Allmed Medical(SZ:002950)2026-01-30 09:25Financial Projections - The estimated net profit attributable to shareholders for 2025 is projected to be between CNY 215.50 million and CNY 257.50 million, representing a decline of 30.16% to 41.55% compared to the previous year[3]. - The estimated net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between CNY 179.50 million and CNY 221.50 million, reflecting a decrease of 35.49% to 47.72% year-over-year[3]. - Basic earnings per share for 2025 are expected to be between CNY 0.35 and CNY 0.41, down from CNY 0.59 in the previous year[3]. - The company plans to recognize impairment provisions for assets showing signs of impairment, which is expected to reduce the total profit for 2025 by CNY 208.63 million[5]. - The financial data in the earnings forecast has not been audited by the accounting firm and is based on preliminary estimates[6]. Business Strategy - The company aims to build a new business growth base by focusing on functional dressings and hygiene care products while expanding its overseas business to mitigate the impact of international trade conflicts[4]. Investor Communication - The company emphasizes the importance of timely information disclosure and advises investors to make cautious decisions and be aware of investment risks[7].